Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 9.33
-0.03 (-0.27%)
Oct 15, 2026, 1:42 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 113.04 million as of October 14, 2026. It is the 22,621st most valuable company in the world and the 489th biggest in the United Kingdom. Its market cap has increased by 14.66% in one year.
Market Cap
113.04M
Enterprise Value
124.80M
Revenue
n/a
Global Rank
Country Rank
#489 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 113.04M, an increase of 3,506.86%. That is a compound annual growth rate of 23.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 113.04M | 10.03% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 306.68M |
| PureTech Health | 277.05M |
| Bioventix | 87.05M |
| 4basebio | 85.50M |
| Faron Pharmaceuticals Oy | 72.43M |
| Hemogenyx Pharmaceuticals | 50.83M |
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 48.86M |